11^th World Kidney Congress

About Conference

Conference Series is delighted to welcome all participants to the “11^th World Kidney Congress” (Kidney Meet 2026), scheduled to be held on April 27–28, 2026, in London, UK, under the theme “Recent Advances and Emerging Future Directions in Nephrology”.

Kidney Meet 2026 will serve as a premier global platform, bringing together renowned experts, researchers, clinicians, and industry professionals to share cutting-edge insights and advancements in nephrology. The congress will showcase pioneering research, emerging technologies, and innovative treatment strategies for kidney-related disorders.

This international event offers an exceptional opportunity to connect with distinguished personalities, explore the latest scientific developments, and engage in thought-provoking discussions that shape the future of nephrology. The program will feature keynote lectures, plenary sessions, oral presentations, poster sessions, workshops, and industry exhibitions.

In addition, the congress is committed to nurturing young researchers through the Poster Award Competition and Young Researchers Forum, encouraging the next generation of nephrology leaders.

Why Attend Kidney Meet 2026?

Kidney Meet 2026 bridges research, clinical practice, and innovation to address kidney-related diseases, promote human health, and enhance patient outcomes. Participants will gain exposure to diverse methodologies, evidence-based case studies, and integrative treatment approaches for chronic and acute kidney disorders.

This congress provides an invaluable opportunity to:

• Exchange ideas with global nephrology leaders.
• Explore new diagnostic, therapeutic, and preventive strategies.
• Collaborate on multidisciplinary approaches for kidney health.
• Network with clinicians, academics, researchers, and industry experts.

Target Audience:

• Nephrologists & Kidney Specialists
• General Physicians & Renal Practitioners
• Urology & Nephrology Professors
• Renal Transplantation Surgeons
• Postdoctoral Researchers & Academicians
• Renal Dietitians & Nutrition Experts
• Young Research Scientists & Students
• Medical and Pharmaceutical Companies
• Laboratory Technicians & Diagnostic Experts
• Business Delegates & Entrepreneurs
• Nephrology and Urology Associations & Societies

Sessions & Tracks

Track 1: Chronic Kidney Disease

Chronic Kidney Disease (CKD) is a progressive condition that impairs kidney function and can lead to severe complications. It is closely linked to diabetes and hypertension, often remaining undetected until advanced stages. Early detection and lifestyle modifications are vital to slow progression. Management strategies include diet, medication, and preventive care.

Key Topics: Diabetes-related CKD | Hypertension-induced CKD

Track 2: Cardiovascular Impact of Kidney Disease

CKD significantly increases the risk of cardiovascular events and early mortality. Even mild kidney damage predisposes patients to heart disease and stroke. Dialysis patients are particularly vulnerable to cardiovascular complications. Preventive cardiology is crucial in nephrology practice.

Key Topics: Heart failure in CKD | Dialysis-related cardiac risks

Track 3: Kidney Transplantation

Kidney transplantation remains the gold standard treatment for end-stage renal disease. Advances in surgical techniques and immunosuppressive drugs have improved outcomes. Long-term success depends on donor compatibility and post-operative care. Research continues on tolerance and rejection prevention.

Key Topics: Living donor transplantation | Immunosuppressive therapy

Track 4: Hypertension and Kidney Health

Hypertension is both a cause and result of kidney dysfunction. Persistent high blood pressure accelerates renal damage, leading to chronic disease. It is closely associated with secondary disorders like vascular nephropathy. Effective blood pressure control slows kidney decline.

Key Topics: Hypertensive nephropathy | Renal vascular disease

Track 5: Pharmacological Approaches in Kidney Disease

Pharmacology plays a vital role in managing CKD and associated conditions. Immunotherapies and targeted drugs are improving patient outcomes. Research also explores integrating traditional remedies with modern medicine. Drug safety and dosage adjustments are crucial for renal patients.

Key Topics: Immunotherapy in nephrology | Drug toxicity in CKD

Track 6: Kidney Failure

Kidney failure occurs when kidneys lose their filtering capacity. It leads to waste accumulation, fluid imbalance, and severe systemic effects. Dialysis and transplantation are life-saving interventions. Early recognition can delay progression to complete renal shutdown.

Key Topics: Acute renal failure | End-stage renal disease

Track 7: Kidney Stones

Kidney stones are solid deposits that obstruct urinary pathways. Risk factors include poor hydration, obesity, and dietary imbalances. Symptoms range from sharp pain to blood in urine. Treatments vary from hydration therapy to surgical removal.

Key Topics: Stone prevention strategies | Surgical stone management

Track 8: Critical Care Nephrology

Critical care nephrology focuses on kidney complications in ICU patients. Dialysis support is essential for those with multi-organ dysfunction. Both hemodialysis and peritoneal dialysis are widely applied. Innovations are enhancing survival rates in critical cases.

Key Topics: Acute kidney injury in ICU | Dialysis modalities in critical care

Track 9: Pediatric and Geriatric Nephrology

Children and elderly patients present unique nephrology challenges. Pediatric care addresses congenital and genetic disorders. Geriatric patients often suffer from late-diagnosed CKD with comorbidities. Tailored care improves long-term survival and quality of life.

Key Topics: Polycystic kidney disease in children | CKD in elderly patients

Track 10: Women’s Health and Pregnancy

Pregnancy places extra strain on kidney function, especially in high-risk women. Pre-existing renal disease increases complications like preeclampsia. Maternal-fetal monitoring is vital for safety. Specialized care ensures better pregnancy outcomes.

Key Topics: Preeclampsia & kidney health | Renal disease in pregnancy

Track 11: Renal Pathology and Immunology

Renal pathology studies immune and structural kidney disorders. Biopsies help diagnose and classify renal diseases. Advanced microscopy provides detailed insights into renal tissue. Immunological research is paving the way for targeted therapies.

Key Topics: Kidney biopsy techniques | Autoimmune renal diseases

Track 12: Mineral and Bone Disorders in CKD

CKD disrupts calcium, phosphorus, and vitamin D metabolism. Patients face higher risk of osteoporosis and bone fractures. Dialysis patients require specialized mineral management. Early detection and treatment prevent skeletal complications.

Key Topics: Renal osteodystrophy | Calcium-phosphorus imbalance

Track 13: Diabetic Nephropathy

Diabetic nephropathy is a leading global cause of CKD. It results from long-term hyperglycemia damaging kidney filtration units. Proteinuria is an early warning sign. Lifestyle changes and strict glucose control delay progression.

Key Topics: Proteinuria in diabetes | Renoprotective therapies

Track 14: Urology

Urology addresses urinary tract, bladder, and prostate-related kidney complications. UTIs and obstructions are common concerns. Early diagnosis prevents renal damage. Advances in minimally invasive urology improve patient outcomes.

Key Topics: Urinary tract infections | Prostate-related kidney disorders

Track 15: Nephrology Nursing

Nephrology nurses provide vital care across dialysis, transplantation, and CKD management. Their role includes patient education and complication prevention. They act as a bridge between patients and medical teams. Specialized training enhances patient outcomes.

Key Topics: Nursing in dialysis care | Patient education in CKD

Track 16: Renal Nutrition

Diet plays a key role in slowing CKD progression. Controlling protein, sodium, and potassium intake is essential. Nutritionists design personalized dietary plans for patients. Proper diet improves treatment tolerance and overall health.

Key Topics: Dietary management in CKD | Nutritional therapy in dialysis

Track 17: Robotic Kidney Transplantation

Robotic-assisted transplantation offers minimally invasive alternatives. It reduces complications and enhances recovery. Surgeons use robotic precision for better outcomes. RAKT is gaining global recognition in renal surgery.

Key Topics: Robotic-assisted surgery | Minimally invasive transplantation

Track 18: Dialysis

Dialysis substitutes lost kidney function by removing waste and toxins. Hemodialysis uses an artificial kidney machine. Peritoneal dialysis relies on the patient’s peritoneum as a filter. Ongoing research enhances patient safety and comfort.

Key Topics: Hemodialysis techniques | Peritoneal dialysis

Track 19: Stem Cells in Renal Disorders

Stem cell research offers hope for kidney repair and regeneration. Mesenchymal cells show protective effects in CKD. Clinical trials explore their role in treating renal injury. This field holds promise for future therapies.

Key Topics: Stem cell therapy in CKD | Regenerative medicine in nephrology

Track 20: Biomarkers in Kidney Disease

Biomarkers help detect kidney damage earlier than traditional tests. They also monitor disease progression and treatment outcomes. Emerging markers provide precision in personalized care. Their use enhances diagnosis and prognosis in nephrology.

Key Topics: Diagnostic biomarkers | Prognostic biomarkers

Track 21: Hematology in Kidney Health

Hematological disorders often accompany kidney disease. Anemia is a frequent complication requiring targeted therapy. Coagulation disorders also impact renal patients. Advanced diagnostics support timely treatment.

Key Topics: Anemia in CKD | Coagulation abnormalities in nephrology

Market Analysis

Kidney Disease Statistics and Global Outlook

According to current health data, kidney diseases represent the 18th leading cause of mortality in Turkey. The national mortality rate due to kidney disorders is estimated at 5.47 per 100,000, with approximately 2.3 million deaths worldwide annually linked to kidney failure. By 2030, the number of individuals requiring dialysis or transplantation is expected to more than double, exceeding 5 million cases. In Istanbul alone, 1 in every 3 adults is at risk of developing kidney disease, and kidney disorders rank as the 9th leading cause of death. Notably, over 600,000 deaths are attributed to kidney diseases in Istanbul each year.

In Turkey, more than 17,000 kidney transplantations were performed in 2014. Of these, 11,570 were from deceased donors, while 5,535 were from living donors. Despite these efforts, 12 patients die every day while waiting for a transplant, and every 10 minutes a new patient is added to the transplant list. In 2014 alone, 4,270 patients died due to delays in transplantation, and 3,617 became too unwell to undergo the procedure.

The economic burden of kidney disease is significant. Annual treatment costs escalate with disease stage — from $15,000 (Stage 3) to $28,000 (Stage 4), and over $70,000 (Stage 5). In the U.S., Medicare spends approximately $28.6 billion annually on patients with kidney failure, while the overall national expenditure on kidney-related care surpasses $41 billion annually, accounting for 17% of the Medicare budget. The National Kidney Foundation (NKF) has invested over $100 million in kidney research to date.

Globally, the prevalence of Chronic Kidney Disease (CKD) is 14%, with hypertension and diabetes as the primary causes. Nearly 50% of CKD patients also report cardiovascular disease (CVD). In the U.S. alone, over 661,000 individuals live with kidney failure — of these, 468,000 are on dialysis, while 193,000 have functioning kidney transplants. CKD often progresses silently without symptoms in early stages, making it a “silent disease.”

The incidence of End-Stage Renal Disease (ESRD) rose sharply in the 1990s, stabilized in the early 2000s, and has slightly declined since 2006. However, disparities remain: ESRD prevalence is 3.7 times higher in African Americans, 1.4 times higher in Native Americans, and 1.5 times higher in Asian Americans compared to Caucasians.

Societies Associated with Nephrology

Middle East:

Kuwait Nephrology Association, Lebanese Society of Nephrology & Hypertension, Iraqi Society of Nephrology, Saudi Society of Nephrology, Syrian Society of Nephrology & Transplantation, Yemen Society for Nephrology and Transplantation

Asia-Pacific:

Asian Pacific Society of Nephrology, Chinese Society of Nephrology, Hong Kong Society of Nephrology, Japanese Society of Nephrology, Korean Society of Nephrology, Mongolian Society of Nephrology and Urology, Taiwan Society of Nephrology, Australian & New Zealand Society of Nephrology, Cambodian Association of Nephrology, Indonesian Society of Nephrology, Myanmar Nephrology Society, Asian Pacific Society of Hypertension, Turkish Society of Hypertension & Atherosclerosis, High Blood Pressure Research Council of Australia, Indonesian Society of Hypertension

Europe & Africa:

Albanian Society of Nephrology, Israel Society of Nephrology & Hypertension, Bosnian Society of Dialysis & Transplantation, Bulgarian Society of Nephrology, Croatian Society of Nephrology, Estonian Society of Nephrology, Austrian Heart Foundation, British Hypertension Society, European Society of Hypertension, Serbian Association of Cardionephrology, Slovenian Society of Nephrology, Turkish Society of Nephrology, German Society of Nephrology, Swiss Society of Nephrology

Americas:

Argentine Society of Nephrology, Bolivian Society of Nephrology, Brazilian Society of Nephrology, Chilean Society of Nephrology, Colombian Society of Nephrology, Costa Rican Society of Nephrology, Cuban Society of Nephrology, Ecuadorian Society of Nephrology, Salvadoran Association of Nephrology & Hypertension, Guatemalan Society of Nephrology, Mexican College of Nephrologists, Nicaraguan Association of Nephrology, Panamanian Society of Nephrology, Paraguayan Society of Nephrology, Peruvian Society of Nephrology, Puerto Rican Society of Nephrology & Hypertension, Uruguayan Society of Nephrology, Venezuelan Society of Nephrology

Hospitals Associated with Nephrology Research

Europe:

Klinik Im Park (Zurich), Health Centre Bad Ragaz, Klinik Pyramide Am See, Klinik Beau-Site (Berne), Hirslanden Clinique La Colline, Lucerne Health, Salem-Spital (Berne), Hirslanden Klinik Aarau, J.W. Goethe University Hospital

Global:

Mayo Clinic, Cleveland Clinic, New York-Presbyterian Hospital, UCSF Medical Center, Brigham & Women’s Hospital, Johns Hopkins Hospital, Massachusetts General Hospital

Universities Associated with Nephrology Research

Albany Medical College, Boston University School of Medicine, Columbia University, David Geffen School of Medicine (UCLA), Florida State University, Georgetown University, Indiana University, Johns Hopkins University, Loma Linda University, Northeastern Ohio Universities, Ohio State University, Tulane University, University of Maryland, Vanderbilt University, Weill Cornell Medical College, Yale University School of Medicine

Major Nephrology Societies Worldwide

• International Society of Nephrology (ISN)
• American Society of Nephrology (ASN)
• Indian Society of Nephrology (ISN)
• Canadian Society of Nephrology (CSN)
• Hong Kong Society of Nephrology (HKSN)
• The Renal Association (UK)
• Australian & New Zealand Society of Nephrology (ANZSN)
• Malaysian Society of Nephrology (MSN)
• National Kidney Foundation (NKF)
• Saudi Society of Nephrology & Transplantation (SSN&T)